公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2024 | HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative | TAI-CHUNG TSENG ; Hosaka, Tetsuya; CHUN-JEN LIU ; Suzuki, Fumitaka; Chiang, Chieh; CHUN-MING HONG ; Kumada, Hiromitsu; Yang, Wan-Ting; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; JIA-HORNG KAO | JHEP reports : innovation in hepatology | | | |
2012 | HBeAg(+) and sex ratio of offspring: Evidence form Taiwan's three million newborns | Lin M.-J.; PEI-JER CHEN ; Luoh M.-C. | American Journal of Human Biology | 4 | 4 | |
2010 | HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses | Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; CHI-LING CHEN ; JIA-HORNG KAO ; Lai M.-Y.; CHEN-HUA LIU ; TUNG-HUNG SU ; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; PEI-JER CHEN ; CHUN-JEN LIU ; DING-SHINN CHEN | Journal of Infectious Diseases | 42 | 37 | |
2024 | HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-related HCC with distinct features | Li, Chiao-Ling; CHIA-LANG HSU ; Lin, You-Yu; MING-CHIH HO ; CHI-LING CHEN ; Ho, Tung-Ching; Lin, Yung-Feng; Tsai, Shih-Feng; Tzeng, Sheng-Tai; Huang, Chin-Fang; Wang, Ya-Chun; Shiou-Hwei Yeh ; PEI-JER CHEN | Liver Cancer | | | |
2020 | HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice | Horng J.-H.; Lin W.-H.; Wu C.-R.; Lin Y.-Y.; Wu L.-L.; Chen D.-S.; PEI-JER CHEN | Journal of Biomedical Science | 11 | 11 | |
2011 | HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection | SHIH-JER HSU ; Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 6 | 5 | |
2016 | Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studies | Grotzinger K.M.; Younossi Z.M.; Giannini E.G.; PEI-JER CHEN ; Rendas-Baum R.; Theodore D. | Health and Quality of Life Outcomes | 2 | 2 | |
2009 | Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage | CHUN-JEN LIU ; PO-HUANG LEE ; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO ; Yang S.-S.; Lee C.-C.; Yu M.-C.; REY-HENG HU ; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN | Journal of Hepatology | 131 | 125 | |
2000 | Hepatic leiomyomatous neoplasm associated with Epstein Barr virus infection in an adult with acquired immunodeficiency syndrome | Wang M.-H.; CHEN-TU WU ; CHIEN-CHING HUNG ; JA-DER LIANG ; PEI-JER CHEN | Journal of the Formosan Medical Association | 14 | 12 | |
2011 | Hepatitis B and Deltavirus Infections | Chen D.-S.; PEI-JER CHEN | Tropical Infectious Diseases | 0 | 0 | |
2022 | Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase | TAI-CHUNG TSENG ; Hosaka, Tetsuya; CHUN-JEN LIU ; Suzuki, Fumitaka; CHUN-MING HONG ; Kumada, Hiromitsu; Yang, Wan-Ting; Hsu, Chen-Yang; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; HSIU-HSI CHEN ; JIA-HORNG KAO | The American journal of gastroenterology | 14 | 12 | |
2002 | Hepatitis B e antigen and the risk of hepatocellular carcinoma | Yang H.-I.; Lu S.-N.; Liaw Y.-F.; You S.-L.; Sun C.-A.; Wang L.-Y.; CHUHSING KATE HSIAO ; PEI-JER CHEN ; Chen D.-S.; Chen C.-J. | New England Journal of Medicine | 1090 | 938 | |
2002 | Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B | Lin C.-L.; Liao L.-Y.; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Gastroenterology | 37 | 37 | |
2000 | Hepatitis B genotypes and the response to interferon therapy | JIA-HORNG KAO ; Wu N.-H.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Hepatology | 453 | 386 | |
2000 | Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Gastroenterology | 879 | 773 | |
2004 | Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma | Chen J.-D.; CHUN-JEN LIU ; PO-HUANG LEE ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Clinical Gastroenterology and Hepatology | 45 | 44 | |
2024 | Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis | Wu, Hsin-Yun; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; JIA-HUEI TSAI ; Wei, Ming-Han; CHIEH-CHANG CHEN ; CHIEN-CHIH TUNG ; JIA-HORNG KAO ; PEI-JER CHEN | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
1993 | Hepatitis B surface antigen and large-form hepatitis delta antigen in HDV assembly: a further study. | PEI-JER CHEN ; Lai W.J.; Wang C.J.; DING-SHINN CHEN | Progress in clinical and biological research | 8 | 0 | |
2014 | Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 13 | 9 | |
2016 | Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection | Yang W.-T.; Wu L.-W; TAI-CHUNG TSENG ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Medicine (United States) | 20 | 15 | |